Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry Meeting Abstract


Authors: Francini, E.; Gray, K. P.; Shaw, G.; Evan, C.; Hamid, A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C.
Abstract Title: Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry
Meeting Title: 2018 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 6 Suppl.
Meeting Dates: 2018 Feb 8-10
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-20
Language: English
ACCESSION: WOS:000436179500199
DOI: 10.1200/JCO.2018.36.6_suppl.203
PROVIDER: wos
Notes: Meeting Abstract: 203 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Philip Wayne Kantoff
    198 Kantoff